232 related articles for article (PubMed ID: 16620956)
1. In vitro re-endothelialization of detergent decellularized heart valves under simulated physiological dynamic conditions.
Lichtenberg A; Tudorache I; Cebotari S; Ringes-Lichtenberg S; Sturz G; Hoeffler K; Hurscheler C; Brandes G; Hilfiker A; Haverich A
Biomaterials; 2006 Aug; 27(23):4221-9. PubMed ID: 16620956
[TBL] [Abstract][Full Text] [Related]
2. Flow-dependent re-endothelialization of tissue-engineered heart valves.
Lichtenberg A; Cebotari S; Tudorache I; Sturz G; Winterhalter M; Hilfiker A; Haverich A
J Heart Valve Dis; 2006 Mar; 15(2):287-93; discussion 293-4. PubMed ID: 16607913
[TBL] [Abstract][Full Text] [Related]
3. Preclinical testing of tissue-engineered heart valves re-endothelialized under simulated physiological conditions.
Lichtenberg A; Tudorache I; Cebotari S; Suprunov M; Tudorache G; Goerler H; Park JK; Hilfiker-Kleiner D; Ringes-Lichtenberg S; Karck M; Brandes G; Hilfiker A; Haverich A
Circulation; 2006 Jul; 114(1 Suppl):I559-65. PubMed ID: 16820637
[TBL] [Abstract][Full Text] [Related]
4. Tissue engineering of heart valves: biomechanical and morphological properties of decellularized heart valves.
Tudorache I; Cebotari S; Sturz G; Kirsch L; Hurschler C; Hilfiker A; Haverich A; Lichtenberg A
J Heart Valve Dis; 2007 Sep; 16(5):567-73; discussion 574. PubMed ID: 17944130
[TBL] [Abstract][Full Text] [Related]
5. Prototype anionic detergent technique used to decellularize allograft valve conduits evaluated in the right ventricular outflow tract in sheep.
Hilbert SL; Yanagida R; Souza J; Wolfinbarger L; Jones AL; Krueger P; Stearns G; Bert A; Hopkins RA
J Heart Valve Dis; 2004 Sep; 13(5):831-40. PubMed ID: 15473487
[TBL] [Abstract][Full Text] [Related]
6. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells.
Fang NT; Xie SZ; Wang SM; Gao HY; Wu CG; Pan LF
Chin Med J (Engl); 2007 Apr; 120(8):696-702. PubMed ID: 17517187
[TBL] [Abstract][Full Text] [Related]
7. Orthotopic replacement of the aortic valve with decellularized allograft in a sheep model.
Baraki H; Tudorache I; Braun M; Höffler K; Görler A; Lichtenberg A; Bara C; Calistru A; Brandes G; Hewicker-Trautwein M; Hilfiker A; Haverich A; Cebotari S
Biomaterials; 2009 Oct; 30(31):6240-6. PubMed ID: 19703713
[TBL] [Abstract][Full Text] [Related]
8. The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning.
Flanagan TC; Cornelissen C; Koch S; Tschoeke B; Sachweh JS; Schmitz-Rode T; Jockenhoevel S
Biomaterials; 2007 Aug; 28(23):3388-97. PubMed ID: 17467792
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of cellular and extracellular matrix composition of native and tissue engineered heart valves.
Schenke-Layland K; Riemann I; Opitz F; König K; Halbhuber KJ; Stock UA
Matrix Biol; 2004 May; 23(2):113-25. PubMed ID: 15246110
[TBL] [Abstract][Full Text] [Related]
10. Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells.
Sodian R; Lueders C; Kraemer L; Kuebler W; Shakibaei M; Reichart B; Daebritz S; Hetzer R
Ann Thorac Surg; 2006 Jun; 81(6):2207-16. PubMed ID: 16731156
[TBL] [Abstract][Full Text] [Related]
11. Histological evaluation of tissue-engineered heart valves implanted in the juvenile sheep model: is there a need for in-vitro seeding?
Dohmen PM; da Costa F; Yoshi S; Lopes SV; da Souza FP; Vilani R; Wouk AF; da Costa M; Konertz W
J Heart Valve Dis; 2006 Nov; 15(6):823-9. PubMed ID: 17152791
[TBL] [Abstract][Full Text] [Related]
12. The independent role of cyclic flexure in the early in vitro development of an engineered heart valve tissue.
Engelmayr GC; Rabkin E; Sutherland FW; Schoen FJ; Mayer JE; Sacks MS
Biomaterials; 2005 Jan; 26(2):175-87. PubMed ID: 15207464
[TBL] [Abstract][Full Text] [Related]
13. The decellularized porcine heart valve matrix in tissue engineering: platelet adhesion and activation.
Kasimir MT; Weigel G; Sharma J; Rieder E; Seebacher G; Wolner E; Simon P
Thromb Haemost; 2005 Sep; 94(3):562-7. PubMed ID: 16268473
[TBL] [Abstract][Full Text] [Related]
14. Challenges in developing a reseeded, tissue-engineered aortic valve prosthesis.
Hof A; Raschke S; Baier K; Nehrenheim L; Selig JI; Schomaker M; Lichtenberg A; Meyer H; Akhyari P
Eur J Cardiothorac Surg; 2016 Sep; 50(3):446-55. PubMed ID: 27084195
[TBL] [Abstract][Full Text] [Related]
15. Evolution of cell phenotype and extracellular matrix in tissue-engineered heart valves during in-vitro maturation and in-vivo remodeling.
Rabkin E; Hoerstrup SP; Aikawa M; Mayer JE; Schoen FJ
J Heart Valve Dis; 2002 May; 11(3):308-14; discussion 314. PubMed ID: 12056720
[TBL] [Abstract][Full Text] [Related]
16. Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: Implications for engineered heart valve tissues.
Engelmayr GC; Sales VL; Mayer JE; Sacks MS
Biomaterials; 2006 Dec; 27(36):6083-95. PubMed ID: 16930686
[TBL] [Abstract][Full Text] [Related]
17. Construction of autologous human heart valves based on an acellular allograft matrix.
Cebotari S; Mertsching H; Kallenbach K; Kostin S; Repin O; Batrinac A; Kleczka C; Ciubotaru A; Haverich A
Circulation; 2002 Sep; 106(12 Suppl 1):I63-I68. PubMed ID: 12354711
[TBL] [Abstract][Full Text] [Related]
18. Preclinical development of tissue-engineered vein valves and venous substitutes using re-endothelialised human vein matrix.
Teebken OE; Puschmann C; Breitenbach I; Rohde B; Burgwitz K; Haverich A
Eur J Vasc Endovasc Surg; 2009 Jan; 37(1):92-102. PubMed ID: 19008126
[TBL] [Abstract][Full Text] [Related]
19. Biomatrix/polymer composite material for heart valve tissue engineering.
Stamm C; Khosravi A; Grabow N; Schmohl K; Treckmann N; Drechsel A; Nan M; Schmitz KP; Haubold A; Steinhoff G
Ann Thorac Surg; 2004 Dec; 78(6):2084-92; discussion 2092-3. PubMed ID: 15561041
[TBL] [Abstract][Full Text] [Related]
20. [A xenogeneic acellularized matrix for heart valve tissue engineering: in vivo study in a sheep model].
Leyh R; Wilhelmi M; Haverich A; Mertsching H
Z Kardiol; 2003 Nov; 92(11):938-46. PubMed ID: 14634763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
